Elevance Health's Q1 results showed stable Medicare utilization and reaffirmed guidance. Click here to find out why ELV stock ...

Elevance continues to expect its Medicare Advantage program to hit 2.2 million to 2.25 million members in 2025, and for adjusted earnings to be $34.15 to $34.85 a share.

In its first quarter 2025 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits company ...

Florida's 23rd congressional district representative, Jared Moskowitz, has recently made several significant transactions in his investment portfolio, according to a congressional trade report. For ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $512.00. The company’s shares closed yesterday at $435.68.

Representative Jared Moskowitz (D-Florida) recently sold shares of Elevance Health, Inc. (NYSE:ELV). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $ ...

Shares of Elevance Health Inc. ELV rallied 1.11% to $435.68 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to ...

Pharmaceutical stocks sank lower Wednesday after President Trump doubled down on his promise to slap tariffs on a long-exempt industry, causing market turmoil globally.

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the health insurance company to provide a report and metrics on the ...

Elevance Health (NYSE:ELV) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...